Search results
Health Benefits of Hydroxymethylbutyrate (HMB)
Health via Yahoo News· 13 hours agoHydroxymethylbutyrate (HMB) is a supplement that can improve muscle function and physical performance. Athletes and older adults may be especially...
Pfizer’s gene therapy for a muscle-wasting disorder misses main goal of late-stage study
WHTC 1450 Holland· 5 days ago(Reuters) - Pfizer said on Wednesday its experimental gene therapy for a type of muscle-wasting...
Study finds LED therapy and antioxidant drug benefit muscle regeneration in Duchenne muscular...
Medical Xpress· 4 days agoAs reported in an article published in the journal PLOS ONE, the strategy prevented muscle...
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Investor's Business Daily· 5 days agoThe news gives Sarepta Therapeutics an edge heading to June 21, when the Food and Drug...
Pfizer's Duchenne gene therapy fails in late-stage study
AOL· 5 days agoThe therapy also did not show a significant difference compared to placebo in secondary goals of the study such the time it takes for patients to rise from the floor or improve speed in a 10 ...
Why Does Your Stomach "Growl"?
Mercola· 1 hour agoYour body lets you know every day, in a variety of ways, that it is alive and well. One such way is the familiar growl of your stomach, which, to most of us, signals hunger. Is All That Noise ...
Avidity Announces Unprecedented AOC 1020 Data from Phase 1/2 FORTITUDE™ Trial Demonstrating Greater...
Morningstar· 6 days agoAvidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced ...
California dreamin'
Politico· 11 hours ago“In [Dončić’s] eyes, the referees are incapable of correctly calling the game, no matter the circumstance. Whining has become muscle memory,” Hendrickson...
Pfizer gene therapy for Duchenne fails to meet goals of key trial
BioPharma Dive via Yahoo Finance· 6 days agoThe negative results from the Phase 3 study, called Ciffreo, come a little more than a month after...
Pfizer setback brings questions for Duchenne gene therapy ahead of Sarepta decision
BioPharma Dive via Yahoo Finance· 5 days agoThe failure of another trial adds to uncertainty around the benefits of the gene-based treatments,...
